Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?

By: via Benzinga
Pfizer Inc. (NYSE: PFE) isn't showing any signs of slowing down with its M&A plans. Just days after announcing it will acquire ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.